The FDA has temporarily suspended clinical trials of the product of its own corporation VіаСеll
- Authors: Stankov D.S., Bersenyev A.V.
- Issue: No 1 (2006)
- Pages: 37-37
- Section: Cell technology
- Submitted: 18.01.2023
- Accepted: 18.01.2023
- Published: 06.03.2023
- URL: https://genescells.ru/2313-1829/article/view/124245
- DOI: https://doi.org/10.23868/gc124245
- ID: 124245
Cite item
Open Access
Access granted
Full Text
About the authors
D. S. Stankov
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
A. V. Bersenyev
Email: redaktor@celltranspl.ru
Russian Federation
References
- Gluckman E., Broxmeyer H.A., Auerbach A.D. et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 1989; 321: 1174-8.
- Cohen Y., Nagler A. Umbilical cord blood transplantation - how, when and for whom? Blood Rev. 2004; 18: 167-79.
Supplementary files
